Leonard Kanavy joins Genentech (www.gene.com) as vice president of commercial operations.
Leonard Kanavy joins Genentech (www.gene.com) as vice president of commercial operations. Kanavy joins Genentech from Novartis Pharmaceutcials, US, where he was vice president of commercial operations.
Anthony P. Hurley was promoted to vice president of fill/finish manufacturing. In his new role, Hurley will continue to lead the South San Francisco commercial and clinical fill/finish operations and will have overall responsibility for the company’s future fill/finish facility in Hillsboro, Oregon. The Oregon site is expected to be licensed and operational in 2010.
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma
February 14th 2025The approval of an ADCETRIS combination regimen is based on positive data from a Phase III trial where the combination regimen demonstrated a clinically meaningful reduction in the risk of death.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.